X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (934) 934
Publication (93) 93
Book Chapter (8) 8
Book Review (4) 4
Data Set (2) 2
Patent (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (378) 378
humans (377) 377
oncology (268) 268
male (260) 260
cancer (208) 208
middle aged (199) 199
aged (196) 196
female (182) 182
urology & nephrology (151) 151
carcinoma, renal cell - drug therapy (132) 132
kidney neoplasms - drug therapy (129) 129
urology (129) 129
survival (122) 122
care and treatment (111) 111
carcinoma, renal cell (103) 103
kidney neoplasms - pathology (103) 103
sunitinib (101) 101
treatment outcome (101) 101
metastasis (100) 100
article (95) 95
prognosis (94) 94
adult (93) 93
renal cell carcinoma (89) 89
aged, 80 and over (82) 82
risk factors (75) 75
antineoplastic agents - therapeutic use (74) 74
retrospective studies (72) 72
prostate cancer (71) 71
carcinoma, renal cell - pathology (68) 68
abridged index medicus (66) 66
hematology, oncology and palliative medicine (66) 66
disease-free survival (63) 63
analysis (62) 62
interferon-alpha (62) 62
sorafenib (62) 62
carcinoma (59) 59
tumors (58) 58
carcinoma, renal cell - mortality (54) 54
neoplasm metastasis (53) 53
everolimus (52) 52
health aspects (51) 51
kidney neoplasms - mortality (51) 51
targeted therapy (50) 50
kidney cancer (49) 49
research (48) 48
therapy (48) 48
vascular endothelial growth factor (47) 47
risk (45) 45
bevacizumab (44) 44
neoplasm staging (44) 44
carcinoma, renal cell - secondary (43) 43
medical colleges (43) 43
chemotherapy (42) 42
mortality (42) 42
carcinoma, renal cell - genetics (41) 41
kidney neoplasms - genetics (41) 41
antineoplastic combined chemotherapy protocols - therapeutic use (39) 39
immunotherapy (39) 39
patient outcomes (39) 39
patients (38) 38
clear cell-type renal cell carcinoma (36) 36
survival analysis (36) 36
trial (36) 36
radical prostatectomy (35) 35
proportional hazards models (34) 34
vascular endothelial growth factor a - antagonists & inhibitors (34) 34
kaplan-meier estimate (33) 33
molecular targeted therapy (33) 33
survival rate (32) 32
men (31) 31
outcomes (31) 31
radiotherapy (31) 31
usage (31) 31
indoles - therapeutic use (30) 30
mutation (30) 30
prostatic neoplasms - therapy (30) 30
pyrroles - therapeutic use (30) 30
time factors (30) 30
risk assessment (29) 29
antineoplastic agents (28) 28
diagnosis (28) 28
drug therapy (28) 28
kidney neoplasms - metabolism (28) 28
randomized controlled trials as topic (28) 28
antineoplastic agents - adverse effects (27) 27
double-blind (27) 27
angiogenesis inhibitors - therapeutic use (26) 26
carcinoma, renal cell - metabolism (26) 26
databases, factual (26) 26
metastases (26) 26
pazopanib (26) 26
phase-iii trial (26) 26
protein kinase inhibitors - therapeutic use (26) 26
seer program (26) 26
antimitotic agents (25) 25
bladder cancer (25) 25
follow-up studies (25) 25
open-label (25) 25
clinical trials (24) 24
expression (24) 24
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 01/2014, Volume 32, Issue 1, p. 5
This review provides a broad overview of emerging data that provide hope that rational precision medicine for metastatic renal cell carcinoma (RCC) may be... 
Biological products industry | Metastasis
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 01/2014, Volume 32, Issue 1, pp. 5 - 15
This review provides a broad overview of emerging data that provide hope that rational precision medicine for metastatic renal cell carcinoma (RCC) may be... 
Biomarkers | Renal cell carcinoma | Prognostic | Predictive
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 05/2016, Volume 13, Issue 5, pp. 246 - 247
Recurrences can occur in up to 30% of surgically managed patients with localized renal cell carcinoma. Existing uro-oncological guidelines differ in... 
PARTIAL NEPHRECTOMY | UROLOGY & NEPHROLOGY | FOLLOW-UP | RISK | Kidney Neoplasms - surgery | Carcinoma, Renal Cell - diagnosis | Humans | Nephrectomy - trends | Carcinoma, Renal Cell - surgery | Neoplasm Recurrence, Local - diagnosis | Neoplasm Recurrence, Local - surgery | Kidney Neoplasms - diagnosis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
by Thorsson, Vesteinn and Thorsson, Vésteinn and Gibbs, Richard A and Gibbs, David L and Brown, Scott D and Wolf, Gregory and Wolf, Denise and Bortone, Dante S and Ou Yang, Tai-Hsien and Porta-Pardo, Eduard and Gao, Galen F and Gao, Jianjiong and Plaisier, Christopher L and Eddy, James A and Ziv, Elad and Culhane, Aedin C and Paull, Evan O and Sivakumar, I.K. Ashok and Gentles, Andrew J and Malhotra, Raunaq and Farshidfar, Farshad and Colaprico, Antonio and Parker, Joel S and Mose, Lisle E and Vo, Nam Sy and Liu, Wenbin and Liu, Jianfang and Liu, Jia and Liu, Yuexin and Liu, Xiuping and Rader, Janet and Dhankani, Varsha and Reynolds, Sheila and Reynolds, Sheila M and Bowlby, Reanne and Califano, Andrea and Cherniack, Andrew D and Anastassiou, Dimitris and Bedognetti, Davide and Mokrab, Younes and Newman, Aaron M and Rao, Arvind and Chen, Amy and Chen, Chu and Chen, Ken and Krasnitz, Alexander and Hu, Jianhong and Hu, Hai and Malta, Tathiane M and Noushmehr, Houtan and Pedamallu, Chandra Sekhar and Bullman, Susan and Ojesina, Akinyemi I and Lamb, Andrew and Zhou, Wanding and Shen, Hui and Choueiri, Toni K and Weinstein, John N and Guinney, Justin and Saltz, Joel and Holt, Robert and Holt, Robert A and Rabkin, Charles S and Caesar-Johnson, Samantha J and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Ferguson, Martin L and Hutter, Carolyn M and Sofia, Heidi J and Tarnuzzer, Roy and Wang, Jioajiao and Wang, Min and Wang, Linghua and Wang, Zhining and Wang, Timothy and Wang, Jing and Yang, Ju Dong and Yang, Hannah and Yang, Liming and Yang, Ian and Zenklusen, Jean C and Zhang, Jiashan (Julia) and Zhang, Jiexin and Zhang, Lizhi and Zhang, Wei and Zhang, Hongzheng and Zhang, Hailei and Zhang, Hongxin and Chudamani, Sudha and Lolla, Laxmi and Naresh, Rashi and Pihl, Todd and Sun, Yichao and Sun, Qiang and Wan, Yunhu and Wu, Ye and Cho, Juok and DeFreitas, Timothy and Frazer, Scott and ... and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Immunity, ISSN 1074-7613, 04/2018, Volume 48, Issue 4, pp. 812 - 830.e14
We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across... 
tumor immunology | immunotherapy | cancer genomics | integrative network analysis | immuno-oncology | tumor microenvironment | immune subtypes | immunomodulatory | GENOMIC ANALYSES | INFORMATION | T-CELL-RECEPTOR | REGULATORY NETWORK | CLASSIFICATION | IMMUNOLOGY | SEQUENCING DATA | SOMATIC MUTATIONS | COMPREHENSIVE ANALYSIS | PREDICTION | REVEALS | Transforming Growth Factor beta - immunology | Prognosis | Humans | Middle Aged | Th1-Th2 Balance - physiology | Male | Neoplasms - classification | Wound Healing - immunology | Young Adult | Transforming Growth Factor beta - genetics | Neoplasms - genetics | Neoplasms - immunology | Interferon-gamma - immunology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Interferon-gamma - genetics | Wound Healing - genetics | Genomics - methods | Child | Macrophages - immunology | Cell proliferation | Cluster analysis | Transcription | Copy number | p53 Protein | Lung cancer | Genomics | Aneuploidy | Lymphocytes T | Genomes | Cell interactions | Macrophages | Immunotherapy | DNA methylation | Deoxyribonucleic acid--DNA | Immune system | Medical research | Wound healing | Immunomodulation | MiRNA | Stockholders | Inflammation | T cell receptors | Communications networks | Gene expression | White blood cells | Inventors | Medical prognosis | γ-Interferon | Mutation | Cancer | Tumors | Immune Subtypes | Integrative Network Analysis | Cancer Genomics | Immuno-oncology | Tumor immunology
Journal Article
Clinical Genitourinary Cancer, ISSN 1558-7673, 07/2019
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 31, pp. 3869 - 3876
Purpose To examine the impact of marital status on stage at diagnosis, use of definitive therapy, and cancer-specific mortality among each of the 10 leading... 
BREAST-CAN